Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
P01CA Nitroimidazole derivatives
P01CA03 Fexinidazole
D11252 Fexinidazole (USAN/INN) <US>
Drug groups [BR:br08330]
Antiparasitic
DG01884 Imidazole antiprotozoal
D11252 Fexinidazole
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11252 Fexinidazole
Antimicrobials [BR:br08307]
Antiparasitics
Agents against Leishmaniasis and Trypanosomiasis
Nitroimidazole derivatives
D11252 Fexinidazole (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11252
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11252
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11252